96 related articles for article (PubMed ID: 12917445)
21. Arginine of retinoic acid receptor beta which coordinates with the carboxyl group of retinoic acid functions independent of the amino acid residues responsible for retinoic acid receptor subtype ligand specificity.
Zhang ZP; Hutcheson JM; Poynton HC; Gabriel JL; Soprano KJ; Soprano DR
Arch Biochem Biophys; 2003 Jan; 409(2):375-84. PubMed ID: 12504905
[TBL] [Abstract][Full Text] [Related]
22. Functional analyses of an LXXLL motif in nuclear receptor corepressor (N-CoR).
Loinder K; Söderström M
J Steroid Biochem Mol Biol; 2004 Aug; 91(4-5):191-6. PubMed ID: 15336696
[TBL] [Abstract][Full Text] [Related]
23. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action.
Shibata H; Spencer TE; Oñate SA; Jenster G; Tsai SY; Tsai MJ; O'Malley BW
Recent Prog Horm Res; 1997; 52():141-64; discussion 164-5. PubMed ID: 9238851
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid.
Egea PF; Mitschler A; Rochel N; Ruff M; Chambon P; Moras D
EMBO J; 2000 Jun; 19(11):2592-601. PubMed ID: 10835357
[TBL] [Abstract][Full Text] [Related]
25. Identification of a novel co-regulator interaction surface on the ligand binding domain of Nurr1 using NMR footprinting.
Codina A; Benoit G; Gooch JT; Neuhaus D; Perlmann T; Schwabe JW
J Biol Chem; 2004 Dec; 279(51):53338-45. PubMed ID: 15456745
[TBL] [Abstract][Full Text] [Related]
26. Molecular determinants of nuclear receptor-corepressor interaction.
Perissi V; Staszewski LM; McInerney EM; Kurokawa R; Krones A; Rose DW; Lambert MH; Milburn MV; Glass CK; Rosenfeld MG
Genes Dev; 1999 Dec; 13(24):3198-208. PubMed ID: 10617569
[TBL] [Abstract][Full Text] [Related]
27. Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR.
Seol W; Mahon MJ; Lee YK; Moore DD
Mol Endocrinol; 1996 Dec; 10(12):1646-55. PubMed ID: 8961273
[TBL] [Abstract][Full Text] [Related]
28. Molecular modeling, affinity labeling, and site-directed mutagenesis define the key points of interaction between the ligand-binding domain of the vitamin D nuclear receptor and 1 alpha,25-dihydroxyvitamin D3.
Swamy N; Xu W; Paz N; Hsieh JC; Haussler MR; Maalouf GJ; Mohr SC; Ray R
Biochemistry; 2000 Oct; 39(40):12162-71. PubMed ID: 11015194
[TBL] [Abstract][Full Text] [Related]
29. A novel nuclear export signal in Smad1 is essential for its signaling activity.
Xiao Z; Brownawell AM; Macara IG; Lodish HF
J Biol Chem; 2003 Sep; 278(36):34245-52. PubMed ID: 12821673
[TBL] [Abstract][Full Text] [Related]
30. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.
Huynh KD; Bardwell VJ
Oncogene; 1998 Nov; 17(19):2473-84. PubMed ID: 9824158
[TBL] [Abstract][Full Text] [Related]
31. A transcriptional co-repressor that interacts with nuclear hormone receptors.
Chen JD; Evans RM
Nature; 1995 Oct; 377(6548):454-7. PubMed ID: 7566127
[TBL] [Abstract][Full Text] [Related]
32. Modulation of retinoic acid receptor alpha activity by lysine methylation in the DNA binding domain.
Huq MD; Ha SG; Wei LN
J Proteome Res; 2008 Oct; 7(10):4538-45. PubMed ID: 18781795
[TBL] [Abstract][Full Text] [Related]
33. A regulatory role for RIP140 in nuclear receptor activation.
Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
[TBL] [Abstract][Full Text] [Related]
34. Polarity-specific activities of retinoic acid receptors determined by a co-repressor.
Kurokawa R; Söderström M; Hörlein A; Halachmi S; Brown M; Rosenfeld MG; Glass CK
Nature; 1995 Oct; 377(6548):451-4. PubMed ID: 7566126
[TBL] [Abstract][Full Text] [Related]
35. Retinoic acid receptor-alpha is stabilized in a repressive state by its C-terminal, isotype-specific F domain.
Farboud B; Privalsky ML
Mol Endocrinol; 2004 Dec; 18(12):2839-53. PubMed ID: 15331758
[TBL] [Abstract][Full Text] [Related]
36. Determinants that control the specific interactions between TAB1 and p38alpha.
Zhou H; Zheng M; Chen J; Xie C; Kolatkar AR; Zarubin T; Ye Z; Akella R; Lin S; Goldsmith EJ; Han J
Mol Cell Biol; 2006 May; 26(10):3824-34. PubMed ID: 16648477
[TBL] [Abstract][Full Text] [Related]
37. Mass-spectrometric analysis of agonist-induced retinoic acid receptor gamma conformational change.
Peterson VJ; Barofsky E; Deinzer ML; Dawson MI; Feng KC; Zhang XK; Madduru MR; Leid M
Biochem J; 2002 Feb; 362(Pt 1):173-81. PubMed ID: 11829754
[TBL] [Abstract][Full Text] [Related]
38. The N-terminal portion of domain E of retinoic acid receptors alpha and beta is essential for the recognition of retinoic acid and various analogs.
Ostrowski J; Hammer L; Roalsvig T; Pokornowski K; Reczek PR
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):1812-6. PubMed ID: 7892182
[TBL] [Abstract][Full Text] [Related]
39. Synergy between signal transducer and activator of transcription 3 and retinoic acid receptor-alpha in regulation of the surfactant protein B gene in the lung.
Yang L; Lian X; Cowen A; Xu H; Du H; Yan C
Mol Endocrinol; 2004 Jun; 18(6):1520-32. PubMed ID: 15044588
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the retinoid orphan-related receptor-alpha coactivator binding interface: a structural basis for ligand-independent transcription.
Harris JM; Lau P; Chen SL; Muscat GE
Mol Endocrinol; 2002 May; 16(5):998-1012. PubMed ID: 11981035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
